Mohammad Barraj Joins Guggenheim KBBO
DUBAI, United Arab Emirates, 2016-05-25 09:00 CEST (GLOBE NEWSWIRE) -- Guggenheim KBBO Partners, a global financial services firm headquartered in Dubai, announced today that it has hired Mohammad Barraj as a Managing Director of Investment Banking.
“Guggenheim KBBO is pleased to welcome Mohammad, who has established a reputation for providing superior client service and counsel over the last 10 years,” said Hani Buttikhi, Senior Executive Officer at Guggenheim KBBO Partners. “We believe our clients will benefit from Mohammad's unique blend of industry knowledge and execution capabilities. As the Guggenheim KBBO platform grows, we will continue to develop our differentiated offering for clients based on our thought leadership and depth of relationships in the region.”
Mr. Barraj joins Guggenheim KBBO Partners from SHUAA Capital psc, where he was a Director in its Investment Banking team in Dubai responsible for the execution of a broad range of high profile mergers, acquisitions, divestitures, capital raising and restructuring transactions. Most recently, he led the closing of Amanat Holdings PJSC’s first investment in the education sector – its acquisition of a strategic stake in Madaares PrJSC (Taaleem) – and advised Emirates National Group on its first cross-border acquisition of a majority stake in Egyptian Advanced Company for Public Transportation S.A.E. His track record also includes advising on landmark healthcare deals including NMC Health plc IPO, Al Noor Hospitals acquisition and sale of CosmeSurge and Emirates Hospital Group, amongst others.
Mr. Barraj earned his Masters of Science in Accounting and Finance from the University of Birmingham in the UK and a Bachelor of Business Administration with merit from the American University of Beirut in Lebanon. He is licensed by the Securities & Commodities Authority in the UAE and holds multiple certifications and awards from the Chartered Institute for Securities & Investment in the UK. Mr. Barraj has been an active CPA license holder since 2007.
About Guggenheim KBBO Partners Limited
Guggenheim KBBO Partners is a DIFC-based joint venture between Guggenheim Partners and the KBBO Group. The firm draws on the global investment banking and asset management capabilities of Guggenheim Partners with KBBO Group’s in-depth industry and market knowledge across the Middle East and beyond to serve clients globally. Guggenheim KBBO Partners is regulated by the DFSA. For more information, visithttp://guggenheimkbbo.com/.
About KBBO Group
KBBO Group is a leading investment group with a diverse portfolio of interests, operating in the UAE and across the Middle East. With a proven track record of successful investments, KBBO Group aims to amplify growth by injecting capital and restructuring debt in already successful companies. In line with the Abu Dhabi 2030 Economic Vision to achieve effective transformation and global integration of the Emirates’ economy, KBBO Group aims to bring about sustainable growth and enduring benefits. Established in 2004, KBBO Group has developed successful expertise in operating a diversified portfolio comprising healthcare, facilities management, real estate development, oil refining & processing, technology, and financial services companies.
About Guggenheim Partners
Guggenheim Partners is a global investment and advisory firm with more than $240 billion1in assets under management. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. For more information, please visitGuggenheimPartners.com.
1Assets under management are as of 03.31.2016 and include consulting services for clients whose assets are valued at approximately $56bn.
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Bombardier Inc.16.11.2018 00:07 | pressemeddelelse
Bombardier Will Fully Cooperate with the AMF Review
Erytech Pharma S.A.15.11.2018 22:06 | pressemeddelelse
ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research
Motiv Inc.15.11.2018 15:01 | pressemeddelelse
Motiv Ring Expands International Footprint and Delivers Industry-First Sizing Process
Crown Bioscience15.11.2018 14:01 | pressemeddelelse
New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments
Biome Grow14.11.2018 14:01 | pressemeddelelse
Biome Grow subsidiary, Highland Grow, receives license to sell to other licensed producers from Health Canada
ADC Therapeutics SA14.11.2018 13:31 | pressemeddelelse
ADC Therapeutics Announces Presentations at 60th American Society of Hematology (ASH) Annual Meeting
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum